MedTrace Logo

KETODEX for Emergence Delirium in Children Undergoing Outpatient Strabismus Surgery

NCT03779282 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2018-12-19

No results posted yet for this study

Summary

Strabismus surgery for children is a very common procedure, with a high incidence of emergence delerium in the recovery room. A combination of intravenous ketamine/dexmedetomidine, or ketodex, has been previously shown to reduce emergence delerium in children undergoing adenotonsillectomy. Here, we study its application in strabismus surgery.

Conditions

  • Emergence Delirium
  • Strabismus

Interventions

DRUG

Dexmedetomidine

see descriptions

Sponsors & Collaborators

  • Ochsner Health System

    lead OTHER

Principal Investigators

  • Khaled Dajani, MD · Ochsner Health System

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-02-15
Primary Completion
2018-09-15
Completion
2018-09-15

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03779282 on ClinicalTrials.gov